Premium
Aprea Therapeutics Inc (APRE)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for h... Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.17 | -6.8 | 2.5 | 2.79 | 2.2101 | 21471 | 2.53095368 | CS |
| 4 | -1.67 | -41.75 | 4 | 4.1002 | 2.2101 | 25014 | 2.94734185 | CS |
| 12 | -1.09 | -31.8713450292 | 3.42 | 5 | 2.2101 | 30810 | 3.53824922 | CS |
| 26 | -0.93 | -28.527607362 | 3.26 | 5.01 | 2.1501 | 27377 | 3.45169193 | CS |
| 52 | -5.82 | -71.4110429448 | 8.15 | 8.4 | 2.1501 | 23287 | 4.44790194 | CS |
| 156 | -29.47 | -92.6729559748 | 31.8 | 40.8 | 0.474 | 139843 | 17.68759395 | CS |
| 260 | -684.67 | -99.6608442504 | 687 | 822.3 | 0.474 | 509089 | 108.20237779 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
